It is a pharma foreign private limited company based in New Delhi, Delhi, India, established in 2023.
2023 | New Delhi, Delhi, India | ActiveDrugs For Neglected Diseases Initiative South Asia Private Limited, a active foreign private limited company, was established on 15 September 2023 in New Delhi, Delhi, India. Engaging in pharma contract r&d within the pharma sector, it holds CIN: U72100DL2023FTC420081. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.10 Cr and a paid-up capital of ₹1.10 Cr.
Its leadership includes Paul Linus Herrling (Director), Rudi Jose L Paye (Director), Kavita Singh (Director). Past directors included Rudi Jose L Paye. Its latest AGM occurred on 26 September 2025, with the balance sheet filed on 31 March 2025. It is based at 2Nd Floor, E-13, Hauz Khas, New Delhi, Delhi, 110016.
U72100DL2023FTC420081
420081
15 September 2023
₹1.10 Cr
₹1.10 Cr
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Drugs For Neglected Diseases Initiative South Asia Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Paul Linus Herrling | Director | 15 Sep 2023 | Current |
| Rudi Jose L Paye | Director | 24 Jan 2024 | Current |
| Kavita Singh | Director | 15 Sep 2023 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 22 Jul 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Drugs For Neglected Diseases Initiative South Asia's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Drugs For Neglected Diseases Initiative South Asia's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Drugs For Neglected Diseases Initiative South Asia, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Drugs For Neglected Diseases Initiative South Asia, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Drugs For Neglected Diseases Initiative South Asia's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Drugs For Neglected Diseases Initiative South Asia Private Limited last Annual general meeting of members was held on 26 Sep 2025 as per latest MCA records. was documented.
The activity Drugs For Neglected Diseases Initiative South Asia Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was completed.
Progress on Rudi Jose L Paye was appointed as a Director was appointed as a Director on 24 Jan 2024 & has been associated with this company since 1 year 10 months . was documented.
Paul Linus Herrling was appointed as a Director was appointed as a Director on 15 Sep 2023 & has been associated with this company since 2 years 2 months . was recorded as a recent event.
The activity Kavita Singh was appointed as a Director was appointed as a Director on 15 Sep 2023 & has been associated with this company since 2 years 2 months . was completed.
Progress on Drugs For Neglected Diseases Initiative South Asia Private Limited was registered on 15 Sep 2023 with Roc Delhi & aged 2 years 2 months as per MCA records. was documented.
The CIN of Drugs For Neglected Diseases Initiative South Asia Private Limited is U72100DL2023FTC420081.
Drugs For Neglected Diseases Initiative South Asia Private Limited is headquartered at 2Nd Floor, E-13, Hauz Khas, New Delhi, Delhi, 110016.
Drugs For Neglected Diseases Initiative South Asia Private Limited was incorporated on 15 September 2023.
The current directors of Drugs For Neglected Diseases Initiative South Asia Private Limited are
The primary industry of Drugs For Neglected Diseases Initiative South Asia Private Limited is Pharma.
Drugs For Neglected Diseases Initiative South Asia Private Limited is unlisted.
The authorized capital of Drugs For Neglected Diseases Initiative South Asia Private Limited is ₹1.10 Cr, and the paid-up capital is ₹1.10 Cr.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX